secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2026-06-02T17:16:53+00:00
Accession:  0001213900-26-064037
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OSR Holdings enters $30M asset purchase agreement with subsidiary Vaximm for VXM01 IP
--------------------------------------------------------------------------------

- $30M purchase price for VXM01 IP; payment deferred until first milestone payment under existing license (Phase 2 completion).
- Milestone trigger: completion of Phase 2 study of VXM01 in glioblastoma or pancreatic cancer.
- Buyer may make voluntary partial payments before milestone; full balance due on milestone date.
- Related-party transaction with subsidiary Vaximm; agreement aimed at Swiss transfer pricing simplification.
- Closing occurs upon full payment; no effect on asset transfer if payment default, subject to good faith resolution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000121390026064037/0001213900-26-064037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000121390026064037/ea0293037-8k_osrhold.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-064037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer